Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension

Clinical trial NCT00138944 · COMPLETED

Trial details

NCT number: NCT00138944
Sponsor: University of Erlangen-Nürnberg Medical School
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2007-01-01
Primary completion: 2008-05-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.